MASTERS OF SCIENCE IN CLINICAL TRIAL SCIENCES
The Masters of Science in Clinical Trial Sciences is housed within the Department of Health Informatics in the Rutger's School of Health Professions. It is a 36 academic credit program consisting of a 9 credit core along with 27 credits of specialization courses and electives. The core curriculum provides foundational information in research design, ethics, drug discovery, and federal & international regulations governing drug and device developmen. The program culminates in a capstone project in which the student can perform a project at their job, participate in a mentored fieldwork experience, or write a systematic review for publication under the guidance of faculty.
The Overall Goal of this Masters degree is to prepare competent individuals to work in the Biopharmaceutical Industries, Regulatory Agencies, Contract Research Organizations or Academia, with the primary objective of assisting with the execution and reporting of clinical drug and device trials commensurate with clinical, legal, ethical, and regulatory guidelines. Specifically students will become familiar with clinical trial fundamentals, especially related to product evaluations for licensing and marketing. Additionally will have a comprehensive understanding of the regulatory and legal framework guiding the planning, execution, completion, and reporting of clnical trialsand be able to perform specific duties based on the student's aread of concentration.
The specialization tracks provide concentrated study in one of four areas:
Clinical Trial Management & Recruitment
Drug Safety & Pharmacovigilance
Specific electives have been outlined for each specialization track but students also have the option of taking a course belonging to one of the other two specialization tracks as their elective.
See Master's Curriculum, click here
See Essential Functions for MS Program Requirements